$1.26
At close: May 14 EDT
$1.24
-0.02-1.59%
Pre-Market: 5:24 AM EDT
Comments
Loading...
NeuroSense Therapeutics Stock Guidance | NASDAQ:NRSN | Benzinga
NeuroSense Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NeuroSense Therapeutics Ltd (NRSN) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for NeuroSense Therapeutics (NRSN)?
There have been no specific sales or earnings guidance reported for NeuroSense Therapeutics in recent months.
Browse guidance and forecast on all stocks.
